STAT January 14, 2021
Andrey Zarur

As a scientist leading a company focused on RNA, I have cheered Pfizer, BioNTech, Moderna, and others as the biopharmaceutical industry raced to create vaccines that will end the tragic loss of life and the economic devastation wrought by Covid-19.

So far, two Covid-19 vaccines, one from Pfizer/BioNTech and one from Moderna, have been approved by the FDA under emergency use authorizations. Both are RNA-based vaccines that show strong efficacy and few side effects. Other vaccines, using other technologies, have been approved for use in other countries.

While RNA science has been developing for two decades, this is the first time we have needed to make billions of doses ASAP. Ingredients for these mRNA vaccines that were stockpiled in advance...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Supply Chain, Technology
The (Upper) Case For Capitalizing Multiracial
Partnering to Provide Digital-Driven Nutrition Services: Attane Health and Anthem Blue Cross Blue Shield
Fauci allies, Covid vaccine officials get ax at NIH
A new COVID variant is on the rise. Here's what to know about LP.8.1
New COVID-19 drug shows greater promise against resistant viral strains

Share This Article